Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in advanced hepatocellular carcinoma
NCT01035229Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2010
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of everolimus in hepatocellular carcinoma (HCC), sponsored by Novartis. Started Apr 2010; status: completed.
02
Drugs
everolimus
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01035229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01035229.